Short interest for Synlogic gives investors a sense of the degree to which investors are betting on the decline of Synlogic's stock. Short interest data is updated every two weeks.

Synlogic Stock (NASDAQ:SYBX), Short Interest Report

Synlogic

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Biotech

Penny Stocks

Markets

Trading Ideas

General

BRNS

SYBX

Synlogic, Inc. (NASDAQ: SYBX) came out with a quarterly loss of $1.71 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $3.60 per share a year ago. These figures are adjusted for non-recurring items.

Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates

vaccine-4892048

News

Synlogic shares are trading lower by 48.4% to $1.78 Friday afternoon. The company announced it will discontinue Synpheny-3, cease operations and reduce its workforce by more than 90%.

Why Synlogic (SYBX) Stock Is Down Nearly 50% Today

Earnings

Eurozone

Commodities

Global

Intraday Update

DOOR

EMKR

Intelligent Bio Solutions Inc. - Common Stock

INBS

PLCE

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 1% on Friday.

The Dow traded down 0.09% to 38,691.21 while the NASDAQ rose 1.26% to 15,992.17. The S&amp;P 500 also rose, gaining, 0.55% to 5,025.21.

Crude Oil Moves Higher; Newell Brands Issues Weak Outlook

Synlogic Inc

WIIM

Intercontinental Exchange shares are trading higher, reversing after falling Thursday on Q1 earnings.

Sea  shares are trading higher after Barclays maintained an Overweight rating on the stock and raised its price target from $68 to $85.

Camden Property Trust shares are trading higher after the company reported better-than-expected Q1 FFO results.

Jefferies analyst Matthew Murphy initiates coverage on Hudbay Minerals (TSX:<a class="ticker" href="https://www.benzinga.com/stock/HBM#TSX">HBM</a>) with a Hold rating and announces Price Target of C$13.

Price Target

Initiation

Analyst Ratings

TSX:HBM

Jefferies Initiates Coverage On Hudbay Minerals with Hold Rating, Announces Price Target of C$13

ANET

Arista Networks shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $240 to $320.

Benchmark analyst Michael Legg maintains Turning Point Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) with a Buy and raises the price target from $34 to $45.

Benchmark Maintains Buy on Turning Point Brands, Raises Price Target to $45

TRMB

Trimble shares are trading lower after the company reported Q1 financial results and issued Q2 financial guidance below estimates.

In the 149 previous Kentucky Derbies, 44 horses have raced from the<a href="https://www.benzinga.com/topic/kentucky-derby">&nbsp;No. 17 post position</a>.
It&#39;s the only post that has not sent a horse to the Winners Circle. In addition, outside that post &mdash; 18, 19 and 20 &mdash; there have been only five winners in 84 attempts.
If there is one horse to end the post 17 jinx at Saturday&#39;s 150th Kentucky Derby, it&#39;s Fierceness.
Better Atmosphere: For the first time in a few years, the Kentucky Derby and the remainder of the Triple Crown races will be taking place without a black cloud over the industry.
<a href="https://www.benzinga.com/news/23/05/32256368/mage-wins-kentucky-derby-following-deaths-of-several-horses-at-churchill-downs">Unlike last year</a>, the seemingly unexplained rash of horse deaths at tracks across the country has subsided.
Also, controversial trainer Bob Baffert will not have any entries.&nbsp;Recall how Baffert was disqualified in 2021 and remains banned <a href="https://www.benzinga.com/news/22/03/25919271/bob-baffert-sues-churchill-downs-over-2-year-ban-following-derby-disqualification-report">for a third year</a>.
As opposed to last year, no other trainer is willing to tarnish their reputation by running a Baffert-trained horse in the race.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35336333/exclusive-blockchain-p2e-virtual-horse-racing-game-photo-finish-announces-new-funding-meet" target="_blank">Virtual Horse Racing Game Photo Finish Announces New Funding &ndash; Meet The Investors And Next Steps</a>
Another Triple Crown Drought? In 1973, Secretariat ended a 25-year drought in winning the Triple Crown &mdash; one of most outstanding feats in sports.
Similar to having three Triple Crown winners in a six-year span during the 1940s, that same feat was replicated with subsequent back-to-back crowns in 1977 (Seattle Slew) and 1978 (Affirmed).
Affirmed&rsquo;s accomplishment marked the beginning of a 36-year drought until American Pharoah accomplished the feat in 2015.
Three years later, Justify captured the crown. The sport is now in the midst of a five-year lapse; in fact, during that period no horse has been able to win the first two legs, let alone prevail with the sweep.
<h2>Blue Grass Stakes Winner Is A Favorite: Sierra Leone</h2>
Over the years, wagering on one of the winners of the major Derby preps has been prudent.&nbsp;
Despite there being a total of 10&nbsp;winners of the Blue Grass Stakes who have gone on to win the Derby, recent history has not been so favorable. The last horse to parlay a victory in Blue Grass into a Kentucky Derby win was Strike The Gold in 1991.
2024 Blue Grass winner Sierra Leone, post position No. 2, has a top-tier trainer in Chad Brown, though Brown has never won the Derby. Sierra Leone is a consistent late-runner, which bodes well for the grueling 1 &frac14; mile race.
Bettors are impressed with the colt, who was in last place at one point in the Blue Grass and eight lengths back at the quarter pole, before galloping to a convincing win.
<h2>Speed Demon As The Other Favorite: Fierceness</h2>
The most impressive Derby prep race victor was the winner of the Florida Derby, Fierceness.
Trained by Hall of Famer Todd Pletcher, who has two Derby wins to his credit, the colt annihilated his competition by coasting to a 13.5 length victory in a blazing 1:48.22, which was more than 2&nbsp;seconds faster than Sierra Leone in the Blue Grass.
This feat was accomplished without a&nbsp;jockey having to urge him along at all. The question remains whether the colt can navigate the stampede of 16 horses to his inside and be in position for a similar final quarter that he displayed in the Florida Derby.
<h2>No Respect For Santa Anita Derby Winner: Stronghold</h2>
One Derby prep that has yielded its fair share of Derby winners over the years is the Santa Anita Derby. If you want to shy away from the co-favorites or are looking for a juicy exacta payout, Stronghold deserves some consideration, with Morning Line odds of 20-1. In six career starts, he has never finished worse than second, with three firsts and three seconds.
In addition, his first career win was at Churchill Downs (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chdn#NASDAQ">CHDN</a>); so he is familiar with the oval. Despite his overall strong performances, wagerers fear Stronghold has not raced enough against top contenders.
Risk-Reward: With two colts attracting most of the bets, the win/place/show, or even exacta payouts could be paltry.
If you are so inclined, there are plenty of longshots. Since 1980, the favored horse has won just 10 times (just 22.7%). Along these lines, another colt with respectable odds in the Morning Line is Louisiana Derby winner&nbsp;Catching Freedom, at 8-1. The horse has been victorious in three of his five races and has increased his speed rating in every outing.
Also, he has already displayed the endurance to race the 1 &frac14; mile Derby, by scoring a victory in the Louisiana Derby at the distance of 1 3/16 mile.
May the horse be with you.
Now Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38566078/exclusive-kentucky-derby-fans-can-score-100k-prize-with-web3-powered-superfecta-scratch-of">EXCLUSIVE&nbsp;</a><a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38566078/exclusive-kentucky-derby-fans-can-score-100k-prize-with-web3-powered-superfecta-scratch-of">&mdash; Kentucky Derby Fans Can Score $100K Prize With Web3-Powered SuperFecta Scratch-Off</a>
Image created using artificial intelligence via Midjourney.

Sports Betting

Previews

CHDN

Can Fierceness End The No. 17 Post Jinx In The Kentucky Derby?

Jefferies analyst George Notter upgrades Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) from Hold to Buy and raises the price target from $240 to $320.

Upgrades

Jefferies Upgrades Arista Networks to Buy, Raises Price Target to $320

Benchmark analyst Todd Brooks maintains BJ's Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJRI#NASDAQ">BJRI</a>) with a Buy and raises the price target from $41 to $45.

BJRI

Benchmark Maintains Buy on BJ's Restaurants, Raises Price Target to $45

Options

OLMA

Olema Pharmaceuticals Option Alert: Oct 18 $15 Calls at the Ask: 156 @ $1.9 vs 1547 OI; Earnings 5/14 After Close [est] Ref=$10.78

Shares of Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) tanked in early trading on Friday, despite the company reporting a<a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38615880/whats-going-on-with-coinbase-stock-after-earnings"> revenue beat for the first quarter</a>.
The results came amid an <a href="https://www.benzinga.com/calendars/earnings">exciting earnings season</a>. Here are some key analyst takeaways from the release.
<ul>
<li>JPMorgan analyst Kenneth Worthington maintained a Neutral rating, while raising the price target from $150 to $175.</li>
<li>Canaccord Genuity analyst Joseph Vafi reaffirmed a Buy rating, while lifting the price target from $240 to $280.</li>
<li>Needham analyst John Todaro reiterated a Buy rating, while reducing the price target from $275 to $260.</li>
<li>HC Wainwright analyst Mike Colonnese maintained a Buy rating, while raising the price target from $300 to $315.</li>
<li>Oppenheimer analyst Owen Lau reaffirmed an Outperform rating, while lifting the price target from $276 to $282.</li>
<li>Wedbush analyst Moshe Katri maintained an Outperform rating, while raising the price target from $200 to $250.</li>
<li>JMP Securities analyst Devin Ryan reiterated a Market Outperform rating and price target of $320.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
JPMorgan: Coinbase reported its first-quarter adjusted earnings of $4.40 per share, ex-crypto investment gains, significantly beating the Street expectations, Worthington said in a note. Total revenues grew 112% year-on-year, with total opex declining -2%, he added.
"It was a solid trading environment for Coinbase in 1Q24 as much of the cryptoecosystem saw significant price appreciation amid key catalysts like distribution innovation (via the spot Bitcoin ETFs) and protocol improvements (like Ethereum's Dencun)," the analyst wrote. He added, however, that the trends seem to have reversed, decelerating so far in the second quarter.
Canaccord Genuity: Coinbase&#8217;s performance in the first quarter "underscores the company&#8217;s aggressive and yet thoughtful approach to garnering broader market share in good and less good crypto market environments," Vafi wrote in a note.
The company adhering to regulations is "paying dividends, with many of the US spot ETF players now using the company as their custodian," the analyst said. Coinbase's model has earnings power, which is being combined with "material cost reductions to the operating model over the last six quarters," he added.
Needham: Coinbase "handily" beat expectations in the first quarter, Todaro said. Revenues of $1.64 billion came in ahead of Street's $1.36 billion, while earnings were $1.96 per share, higher than consensus $1.15 per share, he added.
"In our view COIN is doing almost everything right," the analyst wrote. "The company has managed to keep expenses low, while delivering on derivs, Base chain, ETF trading/custody and an int&#8217;l offering.&#8221;
HC Wainwright: "Coinbase delivered another strong revenue and earnings beat," Colonnese said. Total trading volumes more than doubled sequentially, while both retail and institutional take rates rose in the quarter, driving over $1 billion in total transaction revenues for the first time since the first quarter of 2022, he added.
This combined with subscription and services revenues resulted in a "whopping 20% revenue beat," the analyst stated. "Meanwhile, Coinbase generated more adjusted EBITDA in the quarter than the company did for the full year in 2023 ($1B in 1Q vs. $950M in 2023), demonstrating the strong operating leverage of the business," he further wrote.
Oppenheimer: Coinbase delivered a beat on both the top- and bottom-line, driven by trading volume growth of over 100% sequentially and on a year-on-year basis, Lau said. "Subscription &amp; services revenue was strong, and its 2Q guidance was even better," he added.
The market cap of USDC has risen by $800 million to $33.2 billion from March to May, the analyst stated. "We believe there are catalysts (e.g. further adoption, stablecoin bill, Base, derivative, international expansion) that can support the stock," he further wrote.
Wedbush: Coinbase is growing globally, becoming the "first and largest" crypto exchange in Canada, adding 15 new features to its International Exchange, and covering around 80% of the estimated volume of total futures globally in the first quarter, Katri said.
Coinbase generated more than $300 million in total transaction revenue during April, the analyst stated. He added that subscription and services revenue growth could be between $525 million and $600 million in the second quarter.
JMP Securities: Coinbase delivered a "blowout quarter," benefiting from an improving environment and diversification efforts, Ryan said. Despite high expectations, "we were pleasantly surprised by results on balance," he added.
"While growth from here will not be linear, we think it is becoming more evident to the market that Coinbase is building one of the most holistic on ramps into the digital asset economy, and for virtually all user types," the analyst further wrote.
COIN Price Action: Shares of Coinbase Global had declined by 3.68% to $220.42 at the time of publication on Friday.
Image: Shutterstock

COIN

Coinbase Global Is 'Doing Almost Everything Right': 7 Analysts React To Q1 Results

Benchmark analyst Bill Sutherland reiterates Omnicell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMCL#NASDAQ">OMCL</a>) with a Buy and maintains $38 price target.

Reiteration

OMCL

Benchmark Reiterates Buy on Omnicell, Maintains $38 Price Target

Digital Realty Trust shares are trading higher after the company reported better-than-expected FFO results.

Whales with a lot of money to spend have taken a noticeably bullish stance on Avis Budget Gr.
Looking at options history for Avis Budget Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $175,524 and 6, calls, for a total amount of $378,450.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $90.0 and $120.0 for Avis Budget Gr, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Avis Budget Gr's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Avis Budget Gr's substantial trades, within a strike price spectrum from $90.0 to $120.0 over the preceding 30 days.
<h3>Avis Budget Gr 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714756629_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/07/24</td>
<td>$5.2</td>
<td>$5.1</td>
<td>$5.1</td>
<td>$110.00</td>
<td>$146.3K</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">333</td>
</tr>
<tr>
<td>CAR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/10/24</td>
<td>$19.9</td>
<td>$18.5</td>
<td>$18.5</td>
<td>$96.00</td>
<td>$86.9K</td>
<td style="text-align: right;">649</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CAR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$15.0</td>
<td>$14.3</td>
<td>$15.0</td>
<td>$100.00</td>
<td>$85.5K</td>
<td style="text-align: right;">795</td>
<td style="text-align: right;">68</td>
</tr>
<tr>
<td>CAR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$15.0</td>
<td>$14.1</td>
<td>$15.0</td>
<td>$100.00</td>
<td>$84.0K</td>
<td style="text-align: right;">795</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>CAR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/16/24</td>
<td>$31.7</td>
<td>$29.7</td>
<td>$30.79</td>
<td>$90.00</td>
<td>$61.5K</td>
<td style="text-align: right;">26</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<h3>About Avis Budget Gr</h3>
Avis Budget Group Inc is a provider of automotive vehicle rental and car-sharing services. Its brands include Avis, Budget, and Zipcar. Avis is targeted to serve the premium commercial and leisure segments of the travel industry, while Budget is focused on value-conscious customers. The company operates its own network of rental locations and licenses its brands to franchisees. Zipcar is a car-sharing service that allows members to use the company-owned Zipcar fleet at an hourly rate. The company's largest region by revenue is the Americas.
<h3>Avis Budget Gr's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 535,130, the CAR's price is up by 0.07%, now at $113.85. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 87 days.</li>
</ul>
<h3>Expert Opinions on Avis Budget Gr</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $151.4.
<ul>
<li>Consistent in their evaluation, an analyst from Deutsche Bank keeps a Buy rating on Avis Budget Gr with a target price of $183. </li>
<li>Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on Avis Budget Gr with a target price of $187. </li>
<li>Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Avis Budget Gr, targeting a price of $140. </li>
<li>Maintaining their stance, an analyst from Susquehanna continues to hold a Neutral rating for Avis Budget Gr, targeting a price of $117. </li>
<li>Showing optimism, an analyst from Goldman Sachs upgrades its rating to Neutral with a revised price target of $130. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Avis Budget Gr, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Market Whales and Their Recent Bets on CAR Options

Whales with a lot of money to spend have taken a noticeably bullish stance on Cardinal Health.
Looking at options history for Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 12% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $175,854 and 6, calls, for a total amount of $365,811.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $70.0 to $115.0 for Cardinal Health during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Cardinal Health's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Cardinal Health's significant trades, within a strike price range of $70.0 to $115.0, over the past month.
<h3>Cardinal Health Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714756623_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.1</td>
<td>$2.75</td>
<td>$3.1</td>
<td>$115.00</td>
<td>$139.5K</td>
<td>1.3K</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>CAH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$7.8</td>
<td>$7.0</td>
<td>$7.3</td>
<td>$100.00</td>
<td>$105.1K</td>
<td>183</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CAH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.6</td>
<td>$5.1</td>
<td>$5.2</td>
<td>$95.00</td>
<td>$70.7K</td>
<td>111</td>
<td style="text-align: right;">136</td>
</tr>
<tr>
<td>CAH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.7</td>
<td>$115.00</td>
<td>$68.4K</td>
<td>154</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CAH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/03/24</td>
<td>$20.6</td>
<td>$19.0</td>
<td>$19.02</td>
<td>$80.00</td>
<td>$64.6K</td>
<td>73</td>
<td style="text-align: right;">16</td>
</tr>
</tbody>
</table>

<h3>About Cardinal Health</h3>
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Having examined the options trading patterns of Cardinal Health, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Cardinal Health Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,194,353, the CAH's price is down by -4.37%, now at $98.48. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 102 days.</li>
</ul>
<h3>What Analysts Are Saying About Cardinal Health</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $112.33333333333333.
<ul>
<li>Maintaining their stance, an analyst from Wells Fargo continues to hold a Underweight rating for Cardinal Health, targeting a price of $94. </li>
<li>An analyst from Baird persists with their Outperform rating on Cardinal Health, maintaining a target price of $128. </li>
<li>Maintaining their stance, an analyst from Evercore ISI Group continues to hold a In-Line rating for Cardinal Health, targeting a price of $115. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cardinal Health with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

This Is What Whales Are Betting On Cardinal Health

"<a href="https://www.benzinga.com/cannabis">Cannabis</a> is just getting started and there&#8217;s going to be a lot of companies getting ready to take advantage of this massive growth cycle, government reform, news states, opening new opportunities and one day, interstate commerce." That's according to Benzinga's cannabis stock expert, Michael Berger, who is on a mission to uncover the most promising marijuana stocks poised for growth, even in a dull market.
But these days, the cannabis market is anything but dull. The Drug Enforcement Administration&#8217;s (DEA) historic decision to align its stance with a recommendation from the Department of Health and Human Services and move <a href="https://www.benzinga.com/markets/cannabis/24/04/38530190/breaking-dea-reportedly-moves-to-reschedule-cannabis-stocks-rise-sharply-on-the-news">marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA), </a>left <a href="https://www.benzinga.com/markets/cannabis/24/04/38531355/cannabis-stocks-and-etfs-surge-as-dea-moves-to-reschedule-marijuana">cannabis stocks soaring on Tuesday.</a>
The 19th Benzinga Cannabis Capital Conference is returning to Chicago this Oct. 8-9. <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a> before prices surge by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.
See also: <a href="https://www.benzinga.com/markets/cannabis/24/03/37913874/how-to-make-your-cannabis-business-more-attractive-for-investors-in-2024-advice-on-financial-hea">How To Make Your Cannabis Business More Attractive For Investors In 2024: Advice On Financial Health &amp; Innovatio</a><a href="https://www.benzinga.com/markets/cannabis/24/03/37913874/how-to-make-your-cannabis-business-more-attractive-for-investors-in-2024-advice-on-financial-hea">n</a>
<h3 class="wp-block-heading">Capitalizing On Volatile Opportunity</h3>
Berger who is behind <a href="https://marketfy.com/item/420investor/">Benzinga PotProfits</a> and focuses on helping investors and traders navigate cannabis market highs and lows was genuinely surprised to see a limited interest in trading cannabis stocks among the crowd gathered at gathered at the Benzinga Cannabis Capital Conference in Florida in April.
Benzinga&#8217;s <a href="https://www.benzinga.com/author/javier-hasse">Javier Hasse</a> said the reason is probably a fear of losing hard-earned money by investing in a volatile opportunity.
But now, with regulation come out at the federal level, many can capitalize.
"The opportunity to capitalize on cannabis is now," Berger said. "We help you now navigate these choppy waters, we help you find the alpha and we want to make sure that you&#8217;re able to capitalize on this."
Berger recommended not the be "overexposed" in such a volatile market as cannabis. Instead, he proposes putting "25 of your plant and investment in there and watch out goes." 
"That&#8217;s the strategy we take with the mock portfolio, we make sure that we have, we have powder on the sidelines," Berger explained. "We are ready to capitalize on these swing trades. And if a stock tanks, we&#8217;re able to buy the dip."
He prefers the U.S. cannabis stocks over Canadian, highlighting Green Thumb Industries Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>), Trulieve Cannabis Corp. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/TRUL#CSE">TRUL</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>) and Curaleaf Holdings, Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/CURA#CSE">CURA</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>).
"We&#8217;re focusing on plays that have that global reach, global opportunity and companies that actually have something called free cash flow," Berger said adding other financial metrics to watch out for are net income and adjusted EBITDA.
Now read: <a href="https://www.benzinga.com/markets/cannabis/24/04/38302710/exclusive-focus-on-selling-numbers-not-dreams-thats-what-makes-cannabis-a-good-investment">EXCLUSIVE: Focus On Selling Numbers, Not Dreams, That&#8217;s What Makes Cannabis A Good Investment</a>

Cannabis

Events

Exclusives

CSE:CURA

CSE:TRUL

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

TCNNF

TRUL

EXCLUSIVE: 'Cannabis Is Just Getting Started,' Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades

Investors with a lot of money to spend have taken a bullish stance on Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PANW, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 38 uncommon options trades for Palo Alto Networks.
This isn't normal.
The overall sentiment of these big-money traders is split between 55% bullish and 31%, bearish.
Out of all of the special options we uncovered, 8 are puts, for a total amount of $251,603, and 30 are calls, for a total amount of $2,537,870.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $160.0 and $400.0 for Palo Alto Networks, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Palo Alto Networks's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Palo Alto Networks's significant trades, within a strike price range of $160.0 to $400.0, over the past month.
<h3>Palo Alto Networks Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714756618_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$22.45</td>
<td>$21.1</td>
<td>$22.45</td>
<td>$360.00</td>
<td>$561.2K</td>
<td>1.7K</td>
<td style="text-align: right;">502</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$22.3</td>
<td>$21.35</td>
<td>$22.3</td>
<td>$360.00</td>
<td>$314.4K</td>
<td>1.7K</td>
<td style="text-align: right;">752</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$22.5</td>
<td>$22.5</td>
<td>$22.5</td>
<td>$360.00</td>
<td>$198.0K</td>
<td>1.7K</td>
<td style="text-align: right;">252</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$24.7</td>
<td>$23.8</td>
<td>$23.8</td>
<td>$350.00</td>
<td>$149.9K</td>
<td>1.3K</td>
<td style="text-align: right;">20</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$22.2</td>
<td>$22.05</td>
<td>$22.2</td>
<td>$290.00</td>
<td>$135.4K</td>
<td>1.9K</td>
<td style="text-align: right;">69</td>
</tr>
</tbody>
</table>

<h3>About Palo Alto Networks</h3>
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 85,000 customers across the world, including more than three fourths of the Global 2000.
<h3>Present Market Standing of Palo Alto Networks</h3>
<ul>
<li>Trading volume stands at 1,834,689, with PANW's price down by -0.12%, positioned at $294.98.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 17 days.</li>
</ul>
<h3>Expert Opinions on Palo Alto Networks</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $345.0.
<ul>
<li>An analyst from Oppenheimer persists with their Outperform rating on Palo Alto Networks, maintaining a target price of $330. </li>
<li>Consistent in their evaluation, an analyst from Keybanc keeps a Overweight rating on Palo Alto Networks with a target price of $355. </li>
<li>An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $350. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Palo Alto Networks, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

PANW

Palo Alto Networks Options Trading: A Deep Dive into Market Sentiment

Benchmark analyst Michael Legg reiterates Standex International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXI#NYSE">SXI</a>) with a Buy and maintains $190 price target.

Benchmark Reiterates Buy on Standex International, Maintains $190 Price Target

B. Riley Securities analyst Anna Glaessgen maintains Fox Factory Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXF#NASDAQ">FOXF</a>) with a Neutral and lowers the price target from $50 to $45.

FOXF

B. Riley Securities Maintains Neutral on Fox Factory Hldg, Lowers Price Target to $45

Synlogic shares crater amid company shut down, failed drug study

SUNW and MSS among mid-day movers

Synlogic (SYBX) has released an update. In a bold move to cut costs and maximize shareholder value, a company has announced a drastic 90% workforce...

Synlogic Announces Major Restructuring and Leadership Changes

Synlogic (SYBX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on February 9. Analyst Joseph Schwartz fro...

Hold Rating on Synlogic Amid Discontinued Lead Program and Reduced Price Target

Synlogic (SYBX) has released an update. Synlogic, Inc. has implemented a shareholder rights plan to deter unsanctioned control by potential acquire...

Synlogic Enacts Shareholder Rights Plan for Equitable Control

Synlogic (SYBX) has released an update. Synlogic, Inc. is parting ways with two top executives, President and CEO Aoife Brennan and COO Antoine Awa...

Synlogic Announces Top Executive Departures and Compensation Deals

Synlogic GAAP EPS of -$1.71 misses by $0.74, revenue of $2.77M beats by $0.04M

Synlogic (SYBX – Research Report) received a Hold rating and price target from H.C. Wainwright analyst Ed Arce today. The company's shares opened t...

H.C. Wainwright upgrades Synlogic (SYBX) to a Hold

Leerink Partners analyst Joseph Schwartz reiterated a Hold rating on Synlogic (SYBX – Research Report) on March 19 and set a price target of $1.00....

Hold Rating on Synlogic Amidst Lead Program Discontinuation and Strategic Uncertainties

An announcement from Synlogic (SYBX) is now available. Synlogic, Inc. has appointed James Flynn as a new Class I Director to its Board of Directors...

Synlogic Appoints James Flynn to Board Amidst Director Resignations

BTAI

CLSK

EFSH

EGAN

HKIT

HOLO

LTRX

MLGO

NSTG

SUNW

SYRA

TCBP

ZJYL

Press Releases

Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Sidoti Events, LLC's Virtual November Micro-Cap Conference

Health Care

Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023

Contracts

Synlogic Announces Contract with the Air Force Research Lab

Synlogic Provides Corporate Update and Outlook for 2024

Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria

Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update

Synlogic Adopts Limited Duration Stockholders Rights Plan

Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results

Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Synlogic Stock (NASDAQ:SYBX), Short Interest Report

People Also Watch